Clinical trials
Hyperparathyroidism, Secondary trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 5 |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 4 |
| Amgen | 2 |
| Abbott | 1 |
| Beijing Friendship Hospital | 1 |
| China-Japan Friendship Hospital | 1 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | 1 |
| Huashan Hospital | 1 |
| Kyowa Kirin China Pharmaceutical Co., Ltd. | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperparathyroidism, Secondary | 21 |
| Renal Insufficiency, Chronic | 5 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 2 |
| Cardiovascular Diseases | 1 |
| Hyperparathyroidism | 1 |
| Hyperphosphatemia | 1 |
| Hypocalcemia | 1 |
| Hypoparathyroidism | 1 |
| Kidney Failure, Chronic | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.